Skip to main content

Table 2 Proportion of Eligible Patients on Preventive Medications by Baseline Characteristics

From: Recent hospitalization for Non-coronary events and use of preventive medications for coronary artery disease: An observational cohort study

Characteristic

Prescribed Medication, %

(n = Eligible Patients)

 

Aspirin

(n = 10,296)

B-blocker

(n = 13,148)

ACE-I/ARB

(n = 10,367)

Lipid lowering

(n = 12,949)

All Meds

(n = 8,267)

All eligible patients

58.3

70.2

60.3

64.8

25.0

Age (yrs)

     

   < 55

58.0

65.6

54.3

61.5

23.5

   55-65

59.3

70.3

60.4

66.8

28.3

   65-75

56.2

73.9

64.6

69.2

25.7

   ≥ 75

59.0

68.8

58.9

61.2

21.3

Female

57.6

67.3

60.5

63.3

20.2

Ethnicity

     

   White

60.1

71.7

60.9

66.2

26.1

   Non-white

60.9

69.3

63.6

62.8

25.7

   Unknown

53.5

67.7

57.3

63.0

22.6

Socioeconomic status

     

   Low

57.2

70.3

60.8

63.9

24.4

   Middle

62.1

70.9

60.3

65.0

26.5

   High

50.9

67.3

57.4

68.0

22.5

Current smoker

56.3

66.4

55.9

63.0

23.8

CABG

63.3

79.1

66.5

75.0

32.8

PCI

65.3

77.2

65.4

72.9

32.4

Hypertension

59.1

72.1

64.4

66.7

26.6

Hyperlipidemia

59.7

72.7

62.6

70.6

27.4

Diabetes

62.4

76.3

70.7

68.8

29.8

Heart failure

61.9

76.8

70.0

67.3

30.9

Cerebral vascular disease

59.1

71.2

63.3

66.0

24.5

Peripheral vascular disease

61.1

73.4

64.3

67.5

25.9

Chronic kidney disease

59.2

76.4

60.9

67.5

27.4

COPD

57.7

67.2

59.7

63.5

22.7

  1. Data was complete for all covariates with the exception of ethnicity. ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; COPD = chronic obstructive pulmonary disease.